GLOBUS MEDICAL INC Filed by PAUL DAVID C

Similar documents
GOPHER PROTOCOL INC. Filed by FLEMING STEPHEN M.

CENTERPOINT ENERGY INC Filed by VANGUARD GROUP INC

WASTE MANAGEMENT INC Filed by VANGUARD GROUP INC

ROCKWELL COLLINS INC Filed by VANGUARD GROUP INC

COMCAST CORP Filed by MICROSOFT CORP

NEVADA GOLD & CASINOS INC Filed by HABERKORN STEPHEN J

EXFO INC. FORM SC 13G/A. (Amended Statement of Ownership) Filed 01/19/12

PRINCIPAL FINANCIAL GROUP INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

PURE BIOSCIENCE, INC. Filed by OKUNO DALE

STRAIGHT PATH COMMUNICATIONS INC. Filed by MILLER LLOYD I III

XILINX INC Filed by VANGUARD GROUP INC

AON PLC Filed by CAPITAL RESEARCH & MANAGEMENT CO

NICE SYSTEMS LTD Filed by PSAGOT INVESTMENT HOUSE LTD.

NEWS CORP Filed by SAUD H R H PRINCE ALWALEED BIN TALAL BIN ABDULAZIZ AL

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. HCI Group, Inc. Form: SC 13G/A. Date Filed:

EATON CORP PLC Filed by WELLINGTON MANAGEMENT CO LLP

CASTLE BRANDS INC Filed by CAMULOS CAPITAL LP

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

AMBOW EDUCATION HOLDING LTD. Filed by GIC PRIVATE LTD

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

HASBRO INC Filed by CAPITAL GROUP COMPANIES INC

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

PREFERRED APARTMENT COMMUNITIES INC Filed by WILLIAMS OPPORTUNITY FUND LLC

National American University Holdings, Inc.

VOXELJET AG Filed by TECHNOLOGIE BETEILIGUNGSFONDS BAYERN GMBH & CO. KG

INTERNATIONAL WIRE GROUP INC Filed by BLACKSTONE DISTRESSED SECURITIES ADVISORS LP

OCI PARTNERS LP Filed by OCI N.V.

ST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC

HAWK SYSTEMS, INC. Filed by GREYSTONE BUSINESS CREDIT II, L.L.C.

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

THERAVANCE INC Filed by BAUPOST GROUP LLC/MA

SCHEDULE 13G. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Securities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

MORGAN EQUITIES GROUP, INC. Filed by LOEVNER ROBERT B.

SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934

KINGSTONE COMPANIES, INC.

GENCO SHIPPING & TRADING LTD Filed by OZ MANAGEMENT LP

Pharma-Bio Serv, Inc.

Tallgrass Energy Partners, LP (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.

STRAYER EDUCATION INC Filed by AXA FINANCIAL INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

VERISIGN INC/CA Filed by LONE PINE CAPITAL LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102) Windstream Technologies, Inc.

OWENS CORNING Filed by OWENS CORNING/FIBREBOARD ASBESTOS PERSONAL INJURY TRUST

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

SECURITIES AND EXCHANGE COMMISSION FORM SC 13G. Filing Date: SEC Accession No (HTML Version on secdatabase.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

FORBES ENERGY SERVICES LTD. Filed by WEST FACE CAPITAL INC.

GROUPON, INC. Filed by KEYWELL BRADLEY A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

Tallgrass Energy GP, LP (Name of Issuer)

MOODYS CORP /DE/ Filed by CHILDRENS INVESTMENT FUND MANAGEMENT (UK) LLP

SCHEDULE 13G. Costamare Inc. (Name of Issuer)

Section 1: SC 13G/A (SC 13G/A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SUNOPTA INC. Filed by GRUBER & MCBAINE CAPITAL MANAGEMENT LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Main Street Capital Corp.

ACCESS INTEGRATED TECHNOLOGIES INC

Spark Therapeutics, Inc.

Inventergy Global, Inc (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13D. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

1/11/19. Securities and Exchange Commission 450 Fifth Street NW Washington, DC RE: Schedule 13G Thermon Group Holdings, Inc As of 12/31/18

MARATHON PATENT GROUP, INC.

ShotSpotter, Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Netlist, Inc. (Name of Issuer)

MICHAEL KORS HOLDINGS LTD Filed by FMR LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SCHEDULE 13G (Amendment No. )

3M CO Filed by BLACKROCK INC.

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. REVOLUTION LIGHTING TECHNOLOGIES (Name of Issuer)

TECH DATA CORP Filed by FMR LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Ecology & Environment, Inc.

Alliqua BioMedical, Inc.

united StateS SeCuritieS and exchange COMMiSSiOn Washington, D.C SCHeDuLe 13g

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

VORNADO REALTY TRUST Filed by INTERSTATE PROPERTIES

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

Twilio, Inc. (Name of Issuer)

Recro Pharma, Inc. (Name of Issuer)

Transcription:

GLOBUS MEDICAL INC Filed by PAUL DAVID C FORM SC 13G/A (Amended Statement of Ownership) Filed 02/13/14 Address 2560 GENERAL ARMISTEAD AVENUE AUDUBON, PA, 19403 Telephone 610-930-1800 CIK 0001237831 Symbol GMED SIC Code 3841 - Surgical and Medical Instruments and Apparatus Industry Medical Equipment, Supplies & Distribution Sector Healthcare Fiscal Year 12/31 http://www.edgar-online.com Copyright 2019, EDGAR Online, a division of Donnelley Financial Solutions. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, a division of Donnelley Financial Solutions, Terms of Use.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Globus Medical, Inc. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 379577208 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person s initial filing of this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

CUSIP No. 379577208 Page 2 of 8 1. Name of reporting person I.R.S. identification no. of above person (entities only) David C. Paul 2. Check the appropriate box if a member of a group (a) (b) 3. SEC use only 4. Citizenship or place of organization United States 5. Sole voting power Number of shares beneficially owned by each reporting person with 5,407,976 (1)(2) 6. Shared voting power 20,045,319 (2)(3) 7. Sole dispositive power 5,407,976 (1)(2) 8. Shared dispositive power 20,045,319 (2)(3) 9. Aggregate amount beneficially owned by each reporting person 25,453,295 (2)(3) 10. Check box if the aggregate amount in Row (9) excludes certain shares 11. Percent of class represented by amount in Row (9) 27.8% (4)(5) 12. Type of reporting person IN (1) Consists of (a) 4,898,964 shares of Class B common stock held directly by the reporting person, (b) 435,350 shares of Class B common stock held by the Sonali Paul Trust U/A/D 12/20/12, and (c) 73,662 shares of Class A common stock subject to options held by the reporting person that are exercisable within 60 days of December 31, 2013. (2) The holders of Class B common stock are entitled to 10 votes per share of Class B common stock. Each share of Class B common stock is convertible into the Issuer s Class A common stock on a 1-for-1 basis (a) at any time at the option of the holder of such share, (b) upon the transfer of such share (subject to certain exceptions for transfers not involving a sale, such as transfers not constituting a change in beneficial ownership, estate planning transfers and gifts), and (c) if the Class B common stock held by the holder of such share plus that holder s affiliates represents less than 5% of the Issuer s outstanding common stock. (3) Does not include 1,562,573 shares of Class B common stock held by the Paul Family Irrevocable Trust U/A 4/6/10. The shares are held in trust for the benefit of the reporting person s spouse and children. The reporting person s spouse is trustee of the trust. (4) Based on 66,065,197 shares of Class A common stock outstanding as of December 31, 2013, as reported by the Issuer to the reporting person, plus the number of shares of Class B common stock reported on line 9 that are treated as converted into Class A common stock for the purpose of computing the percentage ownership of the reporting person. (5) Assumes conversion of all of the reporting person s Class B common stock into shares of Class A common stock. 2

CUSIP No. 379577208 Page 3 of 8 1. Name of reporting person I.R.S. identification no. of above person (entities only) Sonali Paul 2. Check the appropriate box if a member of a group (a) (b) 3. SEC use only 4. Citizenship or place of organization United States 5. Sole voting power Number of shares beneficially owned by each reporting person with 1,562,573 (6) 6. Shared voting power 20,045,319 (7)(8) 7. Sole dispositive power 1,562,573 (6) 8. Shared dispositive power 20,045,319 (7)(8) 9. Aggregate amount beneficially owned by each reporting person 21,607,892 (7)(8) 10. Check box if the aggregate amount in Row (9) excludes certain shares 11. Percent of class represented by amount in Row (9) 24.6% (9)(10) 12. Type of reporting person IN (6) Consists of 1,562,573 shares of Class B common stock held by the Paul Family Irrevocable Trust U/A 4/6/10. (7) The holders of Class B common stock are entitled to 10 votes per share of Class B common stock. Each share of Class B common stock is convertible into the Issuer s Class A common stock on a 1-for-1 basis (a) at any time at the option of the holder of such share, (b) upon the transfer of such share (subject to certain exceptions for transfers not involving a sale, such as transfers not constituting a change in beneficial ownership, estate planning transfers and gifts), and (c) if the Class B common stock held by the holder of such share plus that holder s affiliates represents less than 5% of the Issuer s outstanding common stock. (8) Does not include (a) 4,898,964 shares of Class B common stock held directly by the reporting person s spouse, (b) 435,350 shares of Class B common stock held by the Sonali Paul Trust U/A/D 12/20/12, and (c) 73,662 shares of Class A common stock subject to options held by the reporting person s spouse that are exercisable within 60 days of December 31, 2013. (9) Based on 66,065,197 shares of Class A common stock outstanding as of December 31, 2013, as reported by the Issuer to the reporting person, plus the number of shares of Class B common stock reported on line 9 that are treated as converted into Class A common stock for the purpose of computing the percentage ownership of the reporting person. (10) Assumes conversion of all of the reporting person s Class B common stock into shares of Class A common stock. 3

CUSIP No. 379577208 Page 4 of 8 Item 1(a) Name of Issuer Globus Medical, Inc. Item 1(b) Address of Issuer s Principal Executive Offices 2560 General Armistead Avenue Audubon, PA 19403 Item 2(a) Name of Person Filing This Schedule 13G is being filed by David C. Paul and Sonali Paul (together, the Reporting Persons ). Item 2(b) Address of Principal Business Office, or if none, Residence 2560 General Armistead Avenue Audubon, PA 19403 4

CUSIP No. 379577208 Page 5 of 8 Item 2(c) Citizenship The Reporting Persons are citizens of the United States of America. Item 2(d) Title of Class of Securities Class A Common Stock Item 2(e) CUSIP Number 379577208 Item 3. Filing pursuant to Rules 13d-1(b) or 13d-2(b) or (c) Item 4. (a) (b) (c) Ownership Ownership information is provided as of December 31, 2013: Amount beneficially owned: (i) David C. Paul 25,453,295 (11)(12)(13) (ii) Sonali Paul 21,607,892 (12)(14)(15) Percent of class: (i) David C. Paul 27.8% (16)(17) (ii) Sonali Paul 24.6% (16)(17) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote (ii) (A) David C. Paul 5,407,976 (11)(12) (B) Sonali Paul 1,562,573 (12)(14) Shared power to vote or to direct the vote (A) David C. Paul 20,045,319 (12)(13) (B) Sonali Paul 20,045,319 (12)(15) 5

CUSIP No. 379577208 Page 6 of 8 (iii) (iv) Sole power to dispose or to direct the disposition of (A) David C. Paul 5,407,976 (11)(12) (B) Sonali Paul 1,562,573 (12)(14) Shared power to dispose or to direct the disposition of (A) David C. Paul 20,045,319 (12)(13) (B) Sonali Paul 20,045,319 (12)(15) (11) Consists of (a) 4,898,964 shares of Class B common stock held directly by the reporting person, (b) 435,350 shares of Class B common stock held by the Sonali Paul Trust U/A/D 12/20/12, and (c) 73,662 shares of Class A common stock subject to options held by the reporting person that are exercisable within 60 days of December 31, 2013. (12) The holders of Class B common stock are entitled to 10 votes per share of Class B common stock. Each share of Class B common stock is convertible into the Issuer s Class A common stock on a 1-for-1 basis (a) at any time at the option of the holder of such share, (b) upon the transfer of such share (subject to certain exceptions for transfers not involving a sale, such as transfers not constituting a change in beneficial ownership, estate planning transfers and gifts), and (c) if the Class B common stock held by the holder of such share plus that holder s affiliates represents less than 5% of the Issuer s outstanding common stock. (13) Does not include 1,562,573 shares of Class B common stock held by the Paul Family Irrevocable Trust U/A 4/6/10. The shares are held in trust for the benefit of the reporting person s spouse and children. The reporting person s spouse is trustee of the trust. (14) Consists 1,562,573 shares of Class B common stock held by the Paul Family Irrevocable Trust U/A 4/6/10. (15) Does not include (a) 4,898,964 shares of Class B common stock held directly by the reporting person s spouse, (b) 435,350 shares of Class B common stock held by the Sonali Paul Trust U/A/D 12/20/12, and (c) 73,662 shares of Class A common stock subject to options held by the reporting person s spouse that are exercisable within 60 days of December 31, 2013. (16) Based on 66,065,197 shares of Class A common stock outstanding as of December 31, 2013, as reported by the Issuer to the reporting person, plus the number of shares of Class B common stock reported in response to Item 4(a) that are treated as converted into Class A common stock for the purpose of computing the percentage ownership of the reporting person. (17) Assumes conversion of all of the reporting person s Class B common stock into shares of Class A common stock. 6

CUSIP No. 379577208 Page 7 of 8 Item 5. Ownership of Five Percent or Less of a Class Item 6. Ownership of More than Five Percent on Behalf of Another Person Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Item 8. Identification and Classification of Members of the Group Item 9. Notice of Dissolution of Group Item 10. Certification 7

CUSIP No. 379577208 Page 8 of 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2014 8 /s/ David C. Paul David C. Paul /s/ Sonali Paul Sonali Paul